Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Prostaglandin E2 (PGE2), a lipid mediator produced by the cyclooxygenase enzyme system, is the main prostaglandin in the kidney. PGE2 is involved in various physiological and pathophysiological processes in the kidney, including renal hemodynamics, water and salt balance, and renal fibrosis—a key pa...

Full description

Bibliographic Details
Main Authors: Henricus A.M. Mutsaers, Rikke Nørregaard
Format: Article
Language:English
Published: The Korean Society of Nephrology 2022-01-01
Series:Kidney Research and Clinical Practice
Subjects:
Online Access:http://www.krcp-ksn.org/upload/pdf/j-krcp-21-222.pdf
_version_ 1811311947935645696
author Henricus A.M. Mutsaers
Rikke Nørregaard
author_facet Henricus A.M. Mutsaers
Rikke Nørregaard
author_sort Henricus A.M. Mutsaers
collection DOAJ
description Prostaglandin E2 (PGE2), a lipid mediator produced by the cyclooxygenase enzyme system, is the main prostaglandin in the kidney. PGE2 is involved in various physiological and pathophysiological processes in the kidney, including renal hemodynamics, water and salt balance, and renal fibrosis—a key pathological feature of progressive kidney diseases. PGE2 functions by binding to four G-protein-coupled EP receptors (EP1 to EP4), which stimulate different intracellular signaling pathways. The intrarenal distribution of the four EP receptors as well as the different downstream signaling pathways associated with each receptor give rise to the distinct functional consequence of activating each receptor subtype. This review summarizes the current data on the renal expression of the four EP receptors and delineates the role of each receptor in renal fibrosis.
first_indexed 2024-04-13T10:27:54Z
format Article
id doaj.art-f4a0758dd3974a2fb4653f21e13c32f1
institution Directory Open Access Journal
issn 2211-9132
2211-9140
language English
last_indexed 2024-04-13T10:27:54Z
publishDate 2022-01-01
publisher The Korean Society of Nephrology
record_format Article
series Kidney Research and Clinical Practice
spelling doaj.art-f4a0758dd3974a2fb4653f21e13c32f12022-12-22T02:50:16ZengThe Korean Society of NephrologyKidney Research and Clinical Practice2211-91322211-91402022-01-0141141310.23876/j.krcp.21.2226100Prostaglandin E2 receptors as therapeutic targets in renal fibrosisHenricus A.M. Mutsaers0Rikke Nørregaard1 Department of Clinical Medicine, Aarhus University, Aarhus, Denmark Department of Clinical Medicine, Aarhus University, Aarhus, DenmarkProstaglandin E2 (PGE2), a lipid mediator produced by the cyclooxygenase enzyme system, is the main prostaglandin in the kidney. PGE2 is involved in various physiological and pathophysiological processes in the kidney, including renal hemodynamics, water and salt balance, and renal fibrosis—a key pathological feature of progressive kidney diseases. PGE2 functions by binding to four G-protein-coupled EP receptors (EP1 to EP4), which stimulate different intracellular signaling pathways. The intrarenal distribution of the four EP receptors as well as the different downstream signaling pathways associated with each receptor give rise to the distinct functional consequence of activating each receptor subtype. This review summarizes the current data on the renal expression of the four EP receptors and delineates the role of each receptor in renal fibrosis.http://www.krcp-ksn.org/upload/pdf/j-krcp-21-222.pdfchronic kidney diseasecyclooxygenase-2prostaglandin e2renal fibrosis
spellingShingle Henricus A.M. Mutsaers
Rikke Nørregaard
Prostaglandin E2 receptors as therapeutic targets in renal fibrosis
Kidney Research and Clinical Practice
chronic kidney disease
cyclooxygenase-2
prostaglandin e2
renal fibrosis
title Prostaglandin E2 receptors as therapeutic targets in renal fibrosis
title_full Prostaglandin E2 receptors as therapeutic targets in renal fibrosis
title_fullStr Prostaglandin E2 receptors as therapeutic targets in renal fibrosis
title_full_unstemmed Prostaglandin E2 receptors as therapeutic targets in renal fibrosis
title_short Prostaglandin E2 receptors as therapeutic targets in renal fibrosis
title_sort prostaglandin e2 receptors as therapeutic targets in renal fibrosis
topic chronic kidney disease
cyclooxygenase-2
prostaglandin e2
renal fibrosis
url http://www.krcp-ksn.org/upload/pdf/j-krcp-21-222.pdf
work_keys_str_mv AT henricusammutsaers prostaglandine2receptorsastherapeutictargetsinrenalfibrosis
AT rikkenørregaard prostaglandine2receptorsastherapeutictargetsinrenalfibrosis